Performance of the aspartate aminotransferase‐to‐platelet ratio index for the staging of hepatitis C‐related fibrosis: An updated meta‐analysis
Zhong‐Hua Lin, Yong‐Ning Xin, Quan‐Jiang Dong, Qing Wang, Xiang‐Jun Jiang, Shu‐Hui Zhan, Ying Sun, Shi‐Ying Xuan – 7 December 2010 – The aspartate aminotransferase‐to‐platelet ratio index (APRI), a tool with limited expense and widespread availability, is a promising noninvasive alternative to liver biopsy for detecting hepatic fibrosis.
DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia
Randolph P. Matthews, Steven F. EauClaire, Monica Mugnier, Kristin Lorent, Shuang Cui, Megan M. Ross, Zhe Zhang, Pierre Russo, Michael Pack – 7 December 2010 – Infantile cholestatic disorders arise in the context of progressively developing intrahepatic bile ducts. Biliary atresia (BA), a progressive fibroinflammatory disorder of extra‐ and intrahepatic bile ducts, is the most common identifiable cause of infantile cholestasis and the leading indication for liver transplantation in children.
Up‐regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis
Christine Gauglhofer, Sandra Sagmeister, Waltraud Schrottmaier, Carina Fischer, Chantal Rodgarkia‐Dara, Thomas Mohr, Stefan Stättner, Christoph Bichler, Daniela Kandioler, Fritz Wrba, Rolf Schulte‐Hermann, Klaus Holzmann, Michael Grusch, Brigitte Marian, Walter Berger, Bettina Grasl‐Kraupp – 6 December 2010 – Fibroblast growth factors (FGFs) and their high‐affinity receptors [fibroblast growth factor receptors (FGFRs)] contribute to autocrine and paracrine growth stimulation in several nonliver cancer entities.
Relationship between the interleukin‐28b gene polymorphism and the histological severity of hepatitis C virus–induced graft inflammation and the response to antiviral therapy after liver transplantation
Dennis Eurich, Sabine Boas‐Knoop, Martin Ruehl, Maria Schulz, Esperanza D. Carrillo, Thomas Berg, Ruth Neuhaus, Peter Neuhaus, Ulf Peter Neumann, Marcus Bahra – 6 December 2010 – Up to 30% of liver transplants will develop graft cirrhosis within 5 years after liver transplantation (LT) due to recurrent HCV‐infection forwarding accelerated graft damage. Genetic variants of cytokines involved in the immune response may contribute to the degree of graft inflammation, fibrosis progression, and antiviral therapy outcome.
Gender‐specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease
Oyekoya T. Ayonrinde, John K. Olynyk, Lawrence J. Beilin, Trevor A. Mori, Craig E. Pennell, Nicholas de Klerk, Wendy H. Oddy, Peter Shipman, Leon A. Adams – 6 December 2010 – Nonalcoholic fatty liver disease (NAFLD) is a predominantly adult‐diagnosed disorder. Knowledge regarding the epidemiology, phenotype, and metabolic risk factors, during adolescence is limited.
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection
Marie‐Luise Berres, Christian Trautwein, Maximilian Schmeding, Dennis Eurich, Frank Tacke, Marcus Bahra, Peter Neuhaus, Ulf P. Neumann, Hermann E. Wasmuth – 6 December 2010 – The recurrence of liver fibrosis after liver transplantation (LT) for hepatitis C virus (HCV) infection is responsible for graft loss and patient mortality. Although the contribution of the immune system to fibrosis recurrence is anticipated, systematic studies evaluating immune parameters as predictive markers of allograft fibrosis are lacking.
From the bedside to the community: Comparative effectiveness, health services, and implementation research
Catherine Rongey, Hal F. Yee – 6 December 2010
Increased thrombin generation in liver transplant recipients: Does immunosuppressive therapy play a role?
Marco Senzolo, Maria T. Sartori, Kryssia Rodriguez‐Castro, Paolo Simioni, Valeria Rossetto – 6 December 2010
Clinical value of myocardial perfusion scintigraphy as a screening tool in liver transplant candidates
Daniela E. Oprea‐Lager, Bastiaan J. Sorgdrager, J. Wouter Jukema, Roderick W. C. Scherptong, Jan Ringers, Minneke J. Coenraad, Bart van Hoek, Marcel P. M. Stokkel – 3 December 2010 – A cardiac evaluation before orthotopic liver transplantation (OLT) is imperative. Previous investigations have demonstrated that mild to moderate reversible perfusion defects on myocardial perfusion scintigraphy (MPS) in general are associated with a low risk for perioperative cardiac events.